Aprea Net Interest Income from 2010 to 2026
| APRE Stock | USD 0.89 0.01 1.11% |
Net Interest Income | First Reported 2019-03-31 | Previous Quarter 178 K | Current Value 150.7 K | Quarterly Volatility 139.5 K |
Check Aprea Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aprea Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 541.8 K, Selling General Administrative of 8.1 M or Total Revenue of 1.8 M, as well as many indicators such as Price To Sales Ratio of 22.67, Dividend Yield of 0.0 or PTB Ratio of 0.89. Aprea financial statements analysis is a perfect complement when working with Aprea Therapeutics Valuation or Volatility modules.
Aprea | Net Interest Income | Build AI portfolio with Aprea Stock |
Latest Aprea Therapeutics' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Aprea Therapeutics over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Aprea Therapeutics' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aprea Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Aprea Net Interest Income Regression Statistics
| Arithmetic Mean | 371,426 | |
| Coefficient Of Variation | 158.59 | |
| Mean Deviation | 479,619 | |
| Median | (15.00) | |
| Standard Deviation | 589,036 | |
| Sample Variance | 347B | |
| Range | 1.6M | |
| R-Value | 0.81 | |
| Mean Square Error | 124.7B | |
| R-Squared | 0.66 | |
| Significance | 0.000069 | |
| Slope | 94,981 | |
| Total Sum of Squares | 5.6T |
Aprea Net Interest Income History
About Aprea Therapeutics Financial Statements
Aprea Therapeutics stakeholders use historical fundamental indicators, such as Aprea Therapeutics' Net Interest Income, to determine how well the company is positioned to perform in the future. Although Aprea Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aprea Therapeutics' assets and liabilities are reflected in the revenues and expenses on Aprea Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aprea Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 1.5 M | 1.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Aprea Therapeutics is a strong investment it is important to analyze Aprea Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aprea Therapeutics' future performance. For an informed investment choice regarding Aprea Stock, refer to the following important reports:Check out the analysis of Aprea Therapeutics Correlation against competitors. For information on how to trade Aprea Stock refer to our How to Trade Aprea Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aprea Therapeutics. If investors know Aprea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aprea Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.12) | Revenue Per Share | Quarterly Revenue Growth (0.99) | Return On Assets | Return On Equity |
The market value of Aprea Therapeutics is measured differently than its book value, which is the value of Aprea that is recorded on the company's balance sheet. Investors also form their own opinion of Aprea Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aprea Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aprea Therapeutics' market value can be influenced by many factors that don't directly affect Aprea Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aprea Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aprea Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aprea Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.